跳至主要内容
临床试验/NCT05118009
NCT05118009已完成不适用

Artificial Intelligence Based Rapid Identification of ST-elevation Myocardial Infarction Using Electrocardiogram (ARISE)

National Defense Medical Center, Taiwan2 个研究点 分布在 1 个国家目标入组 43,176 人开始时间: 2022年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
43,176
试验地点
2
主要终点
E2C (ECG to coronary angiography) time

研究概览

简要总结

This is a randomized controlled trial (RCT) to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based supporting tool for improving the diagnosis and management of ST-elevation myocardial infarction.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients in emergency department or inpatient department.
  • Patients recieved at least 1 ECG examination.

排除标准

  • The patients recieved ECG at the period of inactive AI-ECG system.

结局指标

主要结局

E2C (ECG to coronary angiography) time

时间窗: Within 6 hours

Time from ECG to activation of coronary angiography for STEMI patients.

次要结局

  • Highest concentration of high-sensitivity cardiac troponin I(Within 3 days)
  • D2C (Door to coronary angiography) time(Within 6 hours)
  • Ejection fractrion(Within 3 days)
  • Highest concentration of creatine kinase(Within 3 days)
  • Length of hospitalization(Within 28 days)
  • Number of CAG event(Within 6 hours)
  • D2B (Door to Balloon Time) time(Within 6 hours)
  • E2B (ECG to primary percutaneous coronary intervention) time(Within 6 hours)

研究者

发起方
National Defense Medical Center, Taiwan
申办方类型
Other
责任方
Principal Investigator
主要研究者

Chin Lin

Associate Professor

National Defense Medical Center, Taiwan

研究点 (2)

Loading locations...

相似试验